Sulphate Removal Induces a Major Conformational Change in Leishmania mexicana Pyruvate Kinase in the Crystalline State

Journal of Molecular Biology

Volumn 383, Issue 3, 2008, Pages 615-626

  Tulloch, Lindsay B ^a   Morgan, Hugh P ^a   Hannaert, Véronique ^b   Michels, Paul A M ^b   Fothergill Gilmore, Linda A ^a   Walkinshaw, Malcolm D ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b DE DUVE INSTITUTE   (Belgium)

Author keywords

conformational transitions; Leishmania mexicana; pyruvate kinase; X ray crystallography

Indexed keywords

AMMONIUM SULFATE; PHOSPHATE; PYRUVATE KINASE; SULFATE; TETRAMER;

AMINO TERMINAL SEQUENCE; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME STRUCTURE; LEISHMANIA MEXICANA; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL;

LEISHMANIA MEXICANA;

EID: 52949125582     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.08.037     Document Type: Article

References (41)

1. Ernest I., Callens M., Opperdoes F.R., and Michels P.A. Pyruvate kinase of Leishmania mexicana mexicana. Cloning and analysis of the gene, overexpression in Escherichia coli and characterization of the enzyme. Mol. Biochem. Parasitol. 64 (1994) 43-54
2. Christofk H.R., Vander Heiden M.G., Harris M.H., Ramanathan A., Gerszten R.E., Wei R., et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452 (2008) 230-233
3. Christofk H.R., Vander Heiden M.G., Wu N., Asara J.M., and Cantley L.C. Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452 (2008) 181-186
4. Allen S., and Muirhead H. Refined three-dimensional structure of cat-muscle (M1) pyruvate kinase at a resolution of 2.6 A. Acta Crystallogr. Sect. D 52 (1996) 499-504
5. Dombrauckas J.D., Santarsiero B.D., and Mesecar A.D. Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. Biochemistry 44 (2005) 9417-9429
6. Jurica M.S., Mesecar A., Heath P.J., Shi W., Nowak T., and Stoddard B.L. The allosteric regulation of pyruvate kinase by fructose-1,6-bisphosphate. Structure 6 (1998) 195-210
7. 2)-ATP-oxalate complex of the rabbit muscle pyruvate kinase at 2.1 Å resolution: ATP binding over a barrel. Biochemistry 37 (1998) 6247-6255
8. +, and l-phospholactate at 2.7 Å resolution. Arch. Biochem. Biophys. 345 (1997) 199-206
9. +, and pyruvate. Biochemistry 33 (1994) 6301-6309
10. Mattevi A., Valentini G., Rizzi M., Speranza M.L., Bolognesi M., and Coda A. Crystal structure of Escherichia coli pyruvate kinase type I: molecular basis of the allosteric transition. Structure 3 (1995) 729-741
11. Rigden D.J., Phillips S.E.V., Michels P.A.M., and Fothergill-Gilmore L.A. The structure of pyruvate kinase from Leishmania mexicana reveals details of the allosteric transition and unusual effector specificity. J. Mol. Biol. 291 (1999) 615-635
12. Valentini G., Chiarelli L., Fortin R., Speranza M.L., Galizzi A., and Mattevi A. The allosteric regulation of pyruvate kinase. J. Biol. Chem. 275 (2000) 18145-18152
13. Valentini G., Chiarelli L.R., Fortin R., Dolzan M., Galizzi A., Abraham D.J., et al. Structure and function of human erythrocyte pyruvate kinase. Molecular basis of nonspherocytic hemolytic anemia. J. Biol. Chem. 277 (2002) 23807-23814
14. Williams R., Holyoak T., McDonald G., Gui C., and Fenton A.W. Differentiating a ligand's chemical requirements for allosteric interactions from those for protein binding. Phenylalanine inhibition of pyruvate kinase. Biochemistry 45 (2006) 5421-5429
15. Suzuli K., Ito S., Shimizu-Ibuka A., and Sakai H. Crystal structure of pyruvate kinase from Geobacillus stearothermophilus. J. Biochem. 144 (2008) 305-312
16. Stuart D.I., Levine M., Muirhead H., and Stammers D.K. Crystal structure of cat muscle pyruvate kinase at a resolution of 2.6 Å. J. Mol. Biol. 134 (1979) 109-142
17. Wooll J.O., Friesen R.H.E., White M.A., Watowich S.J., Fox R.O., Lee J.C., and Czerwinski E.W. Structural and functional linkages between subunit interfaces in mammalian pyruvate kinase. J. Mol. Biol. 312 (2001) 525-540
18. Fenton A.W., and Blair J.B. Kinetic and allosteric consequences of mutations in the subunit and domain interfaces and the allosteric site of yeast pyruvate kinase. Arch. Biochem. Biophys. 397 (2002) 28-39
19. Friesen R.H.E., Castellani R.J., Lee J.C., and Braun W. Allostery in rabbit pyruvate kinase: development of a strategy to elucidate the mechanism. Biochemistry 37 (1998) 15266-15276
20. Mattevi A., Bolognesi M., and Valentini G. The allosteric regulation of pyruvate kinase. FEBS Lett. 389 (1996) 15-19
21. Lee, J.C., Modulation of allostery of pyruvate kinase by shifting of an ensemble of microstates. Acta Biochim. Biophys. Sin. (Shanghai), 40, 663-669.
22. Collins R.A., Kelly S.M., Price N.C., Fothergill-Gilmore L.A., and Muirhead H. Ligand-induced conformational changes in wild-type and mutant yeast pyruvate kinase. Protein Eng. Des. Sel. 9 (1996) 1203-1210
23. Hannaert V., Yernaux C., Rigden D.J., Fothergill-Gilmore L.A., Opperdoes F.R., and Michels P.A.M. The putative effector-binding site of Leishmania mexicana pyruvate kinase studied by site-directed mutagenesis. FEBS Lett. 514 (2002) 255-259
24. Ikeda Y., Tanaka T., and Noguchi T. Conversion of non-allosteric pyruvate kinase isozyme into an allosteric enzyme by a single amino acid substitution. J. Biol. Chem. 272 (1997) 20495-20501
25. Pendergrass D.C., Williams R., Blair J.B., and Fenton A.W. Mining for allosteric information: natural mutations and positional sequence conservation in pyruvate kinase. IUBMB Life 58 (2006) 31-38
26. Hilser V.J., and Thompson E.B. Intrinsic disorder as a mechanism to optimize allosteric coupling in proteins. Proc. Natl. Acad. Sci. 104 (2007) 8311
27. Kern D., and Zuiderweg E.R.P. The role of dynamics in allosteric regulation. Curr. Opin. Struct. Biol. 13 (2003) 748-757
28. Yu S., Lee L.L.Y., and Ching Lee J. Effects of metabolites on the structural dynamics of rabbit muscle pyruvate kinase. Biophys. Chem. 103 (2003) 1-11
29. Collins R.A., McNally T., Fothergill-Gilmore L.A., and Muirhead H. A subunit interface mutant of yeast pyruvate kinase requires the allosteric activator fructose 1,6-bisphosphate for activity. Biochem. J. 310 (1995) 117
30. Hayward S., and Berendsen H.J.C. Systematic analysis of domain motions in proteins from conformational change: new results on citrate synthase and T4 lysozyme. Proteins 30 (1998) 144-154
31. Henzler-Wildman K.A., Thai V., Lei M., Ott M., Wolf-Watz M., Fenn T., et al. Intrinsic motions along an enzymatic reaction trajectory. Nature 450 (2007) 838-844
32. Kuriyan J., and Eisenberg D. The origin of protein interactions and allostery in colocalization. Nature (London) 450 (2007) 983
33. Popovych N., Sun S., Ebright R.H., and Kalodimos C.G. Dynamically driven protein allostery. Nat. Struct. Mol. Biol. 13 (2006) 831-838
34. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
35. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
36. Bailey S. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. Sect. D 50 (1994) 760-763
37. Powell H.R. The Rossmann Fourier autoindexing algorithm in MOSFLM. Logo 55 (1999) 1690-1695
38. Lebedev A.A., Vagin A.A., and Murshudov G.N. Model preparation in MOLREP and examples of model improvement using X-ray data. Logo 64 (2008) 33-39
39. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. Sect. D 53 (1997) 240-255
40. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. Sect. D 60 (2004) 2126-2132
41. DeLano W.L. The PyMOL Molecular Graphics System (2002), DeLano Scientific, San Carlos, CA